Barclays PLC Sells 14,018 Shares of Globe Life Inc. $GL

Key Points

• Barclays PLC trimmed its stake in Globe Life by 4.8%, selling 14,018 shares and leaving 277,507 shares worth about $39.7M, while institutional investors hold roughly 81.6% of the stock.
• Insiders — including CEO Frank M. Svoboda (sold 12,500 shares) and Director Mark A. Blinn (sold 1,750 shares) — disposed of 92,186 shares in the last quarter valued at $13.36M, cutting insider ownership to about 1.97%.
• Globe Life slightly missed quarterly estimates (EPS $3.39 vs. $3.44 est.; revenue $1.52B vs. $1.53B) but set FY2026 guidance of 14.95–15.65 EPS (above analyst expectations ~13.87) and raised its quarterly dividend to $0.33 (annual $1.32, yield ~0.9%).

Barclays PLC trimmed its holdings in shares of Globe Life Inc. (NYSE:GL - Free Report) by 4.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 277,507 shares of the company's stock after selling 14,018 shares during the quarter. Barclays PLC owned 0.35% of Globe Life worth $39,675,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Mather Group LLC. bought a new stake in Globe Life during the 3rd quarter valued at about $28,000. CYBER HORNET ETFs LLC bought a new position in Globe Life in the 2nd quarter worth about $28,000. Assetmark Inc. grew its stake in Globe Life by 777.8% in the 2nd quarter. Assetmark Inc. now owns 237 shares of the company's stock worth $29,000 after acquiring an additional 210 shares in the last quarter. MUFG Securities EMEA plc purchased a new position in shares of Globe Life during the second quarter worth approximately $31,000. Finally, Quent Capital LLC purchased a new position in shares of Globe Life during the third quarter worth approximately $36,000. 81.61% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Globe Life

In related news, Director Mark A. Blinn sold 1,750 shares of the stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $147.91, for a total transaction of $258,842.50. Following the completion of the sale, the director owned 3,372 shares of the company's stock, valued at $498,752.52. This represents a 34.17% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Frank M. Svoboda sold 12,500 shares of the firm's stock in a transaction that occurred on Tuesday, February 17th. The shares were sold at an average price of $144.78, for a total transaction of $1,809,750.00. Following the completion of the sale, the chief executive officer owned 35,868 shares of the company's stock, valued at approximately $5,192,969.04. This trade represents a 25.84% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 92,186 shares of company stock valued at $13,358,379. 1.97% of the stock is currently owned by corporate insiders.

Globe Life Stock Up 0.6%

Shares of NYSE GL opened at $142.92 on Wednesday. Globe Life Inc. has a 12-month low of $109.38 and a 12-month high of $152.71. The stock's fifty day simple moving average is $142.07 and its two-hundred day simple moving average is $139.01. The stock has a market capitalization of $11.24 billion, a PE ratio of 10.15 and a beta of 0.46. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.39.

Globe Life (NYSE:GL - Get Free Report) last released its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 EPS for the quarter, missing the consensus estimate of $3.44 by ($0.05). The company had revenue of $1.52 billion during the quarter, compared to the consensus estimate of $1.53 billion. Globe Life had a return on equity of 21.30% and a net margin of 19.37%.The company's revenue was up 3.6% on a year-over-year basis. During the same period in the previous year, the firm posted $3.14 earnings per share. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. As a group, analysts expect that Globe Life Inc. will post 13.87 EPS for the current fiscal year.

Globe Life Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 1st. Shareholders of record on Friday, April 3rd will be issued a $0.33 dividend. This is a boost from Globe Life's previous quarterly dividend of $0.27. This represents a $1.32 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Thursday, April 2nd. Globe Life's dividend payout ratio is presently 7.67%.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the company. Truist Financial lifted their target price on Globe Life from $158.00 to $180.00 and gave the company a "buy" rating in a research report on Friday, February 6th. Weiss Ratings upgraded Globe Life from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Friday, February 13th. Piper Sandler restated an "overweight" rating and issued a $167.00 price objective on shares of Globe Life in a report on Friday, November 21st. Wells Fargo & Company upped their price objective on shares of Globe Life from $170.00 to $171.00 and gave the stock an "overweight" rating in a research note on Wednesday, February 25th. Finally, TD Cowen reiterated a "buy" rating on shares of Globe Life in a report on Thursday, December 11th. Eight investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, Globe Life has an average rating of "Moderate Buy" and an average target price of $171.33.

Globe Life Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company's product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.

Want to see what other hedge funds are holding GL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globe Life Inc. (NYSE:GL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.